IP Library › Assignment 014250/0979
Patent Assignment
Reel/Frame 014250/0979

Security Agreement

Recorded: 2004-01-14 Received: 2004-01-14 Pages: 19
Assignor
ADVISYS INC.
Executed: 2003-12-22
Assignee
ESTATE OF GORDAN A. CAIN
8 GREENWAY PLAZA, SUITE 792, C/O JAMES D. WEAVER, EXECUTOR, HOUSTON, TX, 77046, UNITED STATES
Covered Properties (16)
Constant Current Electroporation Device and Methods of Use
Application: 10/657,725 →
Canine-specific growth hormone releasing hormone
Application: 60/492,427 →
Codon Optimized Synthetic Plasmids
Application: 10/619,939 →
Devices and methods for biomaterial production
Application: 60/474,749 →
Plasmid mediated GHRH supplementation for renal failures
Application: 60/464,266 →
Increased delivery of a nucleic acid construct in vivo by the poly-L-glutamate ("PLG") system
Application: 10/395,709 →
Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications
Application: 60/454,079 →
Modified Pituitary Gland Development in Offspring from Expectant Mother Animals Treated with Growth Hormone Releasing Hormone Therapy
Application: 10/359,919 →
Reducing culling in herd animals growth hormone releasing hormone (GHRH)
Application: 60/443,104 →
Treating Anemia in Subjects by Administration of Plasmids Encoding Growth Hormone Releasing Hormone
Application: 10/315,907 →
Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells
Application: 60/423,536 →
Super-active porcine growth hormone releasing hormone analog
Application: 10/262,377 →
Polynucleotides Encoding a Super-Active Porcine Growth Hormone Releasing Hormone Analog
Application: 10/262,141 →
Protease resistant ti-growth hormone releasing hormone
Application: 10/166,356 →
Electrode Assembly for Constant-Current Electroporation and Use
Application: 10/360,768 →
Administration of nucleic acid sequence to female animal to enhance growth in offspring